Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BUDEOE: Viscous Budesonide in Pediatric Eosinophilic Esophagitis
2024-512395-36-00Phase 2Withdrawn
- Sponsor
- Policlinico di Bari
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of budesonide in eosinophilic esophagitis (EoE), sponsored by Policlinico di Bari. Planned start Dec 2024; status: withdrawn.
02
Drugs
budesonide
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on 2024-512395-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512395-36-00.